Dr. Mebrahtom W. Tesfai, MD

Dr. Tesfai practices at MUSC Health Lancaster Medical Center in Lancaster, South Carolina, part of Medical University of South Carolina.

Dr. Tesfai's NPI, 1023297397, was assigned on November 2, 2007. Dr. Tesfai holds South Carolina license 40101.

Dr. Tesfai's primary practice is MUSC Health Lancaster Medical Center, at 800 W Meeting St, Lancaster, SC 29720 in Lancaster County. The practice phone is (803) 286-1481.

Dr. Tesfai's primary practice is MUSC Health Lancaster Medical Center in Lancaster, South Carolina, part of Medical University of South Carolina. Dr. Tesfai is also affiliated with MUSC Health Chester Medical Center. The medical group on file is MUSC Community Physicians. Dmand AI also links Dr. Tesfai to 1 more hospital and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tesfai practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Tesfai's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Tesfai is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Tesfai's licenses on file in 2 states: South Carolina and North Carolina.

CMS data shows 780 Medicare services from Dr. Tesfai across 5 procedure codes in 2024, for 235 Medicare patients. Medicare paid $64,613 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 235 Medicare patients who saw Dr. Tesfai in 2024. The largest group is 75 to 84, with 89 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tesfai's median patient age at 65, with 55% women.

In 2024, Dr. Tesfai wrote 263 Medicare Part D claims for 127 patients. 82% of them were for generic drugs. CMS names the drug for 123 of them, across 7 drugs with 11 or more claims each, at $6,394 in total drug cost. In 2023, CMS named 110 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Tesfai for performance year 2024, reported as part of a group. Dr. Tesfai accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 4 general payments to Dr. Tesfai from 3 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) paid the most, $74.